Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study-Reference-Cited by-同舟云学术

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study

Published:2016-04-23 Issue:1 Volume:17 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Silkoff P. E., ,Laviolette M.,Singh D.,FitzGerald J. M.,Kelsen S.,Backer V.,Porsbjerg C.,Girodet P. O.,Berger P.,Kline J. N.,Khatri S.,Chanez P.,Susulic V. S.,Barnathan E. S.,Baribaud F.,Loza M. J.

Funder

Janssen R&D Inc of the Johnson and Johnson Group of Companies

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-016-0360-5

Reference27 articles.

1. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088–98.

2. Brightling CE, Chanez P, Leigh R, O'Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med. 2015;3:692–701.

3. Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID, Investigators S. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371:1189–97.

4. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360:973–84.

5. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651–9.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal hierarchical Bayesian models of covariate effects on airway and alveolar nitric oxide;Scientific Reports;2023-04-01

2. Interval change in fractional exhaled nitric oxide (FENO) reflects short-term change in adherence following electronic inhaler reminders;Journal of Asthma;2023-02-06

3. Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study;International Journal of Chronic Obstructive Pulmonary Disease;2023-01

4. Longitudinal Hierarchical Bayesian models of covariate effects on airway and alveolar nitric oxide;2022-10-13

5. Type 2 or Non–Type 2 Asthma Exacerbations? That Is the Question;American Journal of Respiratory and Critical Care Medicine;2022-09-01